Anti-Eph receptor A2+A3+A4 (phospho Y588 + Y596) antibody (ab62256)

Publishing research using ab62256? Please let us know so that we can cite the reference in this datasheet.

ab62256 has been referenced in 3 publications.

  • Mansour M  et al. PTP-PEST controls EphA3 activation and ephrin-induced cytoskeletal remodelling. J Cell Sci 129:277-89 (2016). WB ; Human . PubMed: 26644181
  • Sabet O  et al. Ubiquitination switches EphA2 vesicular traffic from a continuous safeguard to a finite signalling mode. Nat Commun 6:8047 (2015). PubMed: 26292967
  • Sharonov GV  et al. Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase. J Biol Chem 289:14955-64 (2014). ICC/IF ; Human . PubMed: 24733396

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up